The Science Behind Targeted Treatments and Immunotherapies for Bowel Cancer
The aim of this morning’s course is to provide an up-to-date overview of targeted treatments and immunotherapies given to people with bowel cancer. This includes EGFR-targeted antibodies, B-Raf & MEK inhibitors, immunotherapies, and treatment combinations currently being investigated in clinical trials.
Elaine’s goal is to explain the science that underpins each treatment and to provide learners with a broad understanding of why treatments work well for some patients but not for others.
This course builds on two mornings on targeted treatments and immunotherapies for solid tumours on 03 & 04 December.
Audience: Ideal for pharmacists, research nurses, pharmaceutical companies, junior doctors or anyone who has been on one of Elaine’s other courses
To book, contact: firstname.lastname@example.org
View the programme